The plant-based vaccines market utilizes plants as bioreactors to produce vaccine antigens for efficient prevention and treatment of various diseases such as influenza, hepatitis B, human papillomavirus, and others. Plant-based production platforms offer several advantages over egg-based and cell-based platforms including low-cost, rapid scalability, lack of human pathogens, and capability for complex post-translational modifications. The use of plants as bioreactors for expression of antigenic proteins eliminates the need for costly fermentation and containment facilities required for traditional cell culture-based platforms.
Key Takeaways
Key players operating in the plant-based vaccines market are Medicago, Inc., IBIO, Inc., Icon Genetics GmbH, Lumen Bioscience, Inc., British American Tobacco Plc., Creative Biolabs, Inc., Leaf Expression Systems Ltd., ZYUS Life Sciences Inc., PlantForm Corporation, and Infectious Disease Research Institute (IDRI). With increasing R&D investments, these players are developing novel plant-based vaccine candidates against major human and animal pathogens.
The low-cost and rapid scalability offered by plant-based production platforms provide opportunities to develop new and affordable vaccines. Additionally, plant-based vaccines can address the problem of vaccine shortages in developing countries by enabling quick production ramp-up to meet urgent public health needs.
Several companies are also exploring global expansion strategies by establishing new production facilities, manufacturing partnerships, and clinical trials in key markets such as North America, Europe, Asia Pacific and Latin America to cater to the growing demand for plant-based vaccines worldwide.
Market drivers
One of the key driver for the plant-based vaccines market is the lower production costs as compared to traditional cell culture and egg-based platforms. Plants do not require the costly fermentation and containment facilities, sophisticated cell culture media and buffers required for conventional platforms. This makes plant-based vaccines significantly cheaper to produce.
Market restraints
Despite the advantages, some technological challenges still remain for the development of plant-based vaccines. Ensuring proper folding, glycosylation and assembly of vaccine antigens continues to be an area of active research. Concerns over potential allergic reactions to plant-based constituents may also limit large-scale adoption initially. However, these issues are being addressed through ongoing advancements in plant molecular farming.
Segment Analysis
This market can be segmented by source, technology and application. In terms of source, the Plant-Based Vaccines Market Demand produced from tobacco plants dominates the market as tobacco plants provide high yields and consistency in production. Regarding technology, the transgenic technology leads as it allows the production of recombinant subunit vaccines from transgenic plant tissues like leaves. Application-wise, infectious disease vaccination holds a significant share since several plant-based vaccines are in trials for diseases like influenza, hepatitis B etc. Infectious disease vaccination from plant-based platforms is emerging as a cost-effective alternative to traditional egg-based or animal cell culture methods.
Global Analysis
Regionally, North America holds the largest share in the plant-based vaccines market owing to the concentration of key players and rising R&D investments in the field. However, Asia Pacific is expected to grow at the fastest pace during the forecast period due to increasing government support for vaccine development and manufacturing in countries like India and China. The availability of low-cost labor and biological resources in Asia Pacific provides an impetus for market growth. Additionally, transitions in demographics and disease epidemiology in developing Asian economies like India necessitate the development of new low-cost vaccine technologies like plant-based platforms.
Explore more information on this topic, Please visit -
https://www.trendingwebwire.com/plant-based-vaccines-market-growth-and-forecasts-analysis/
Explore more trending article -
https://www.insightprobing.com/vertical-farming-market-size-and-trends-analysis/
Comments
0 comment